We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
-1.14%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$542M
AUM Growth
-$294M
Cap. Flow
-$267M
Cap. Flow %
-49.33%
Top 10 Hldgs %
48.31%
Holding
524
New
97
Increased
7
Reduced
21
Closed
262

Top Buys

Rank Stock Value
1
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$67.8M
2
SLGC
SomaLogic, Inc. Class A Common Stock
SLGC
+$16.8M
3
UP icon
Wheels Up
UP
+$12.9M
4
CRBU icon
Caribou Biosciences
CRBU
+$11M
5
MRVI icon
Maravai LifeSciences
MRVI
+$9.02M

Top Sells

Rank Stock Value
1
AVAH icon
Aveanna Healthcare
AVAH
+$21.7M
2
ATIP
ATI Physical Therapy, Inc.
ATIP
+$21.6M
3
AGTI
Agiliti Inc
AGTI
+$19.1M
4
QSI icon
Quantum-Si Incorporated
QSI
+$15.3M
5
GENI icon
Genius Sports
GENI
+$15.1M

Sector Composition

Rank Sector Weight
1 Healthcare 26.94%
2 Financials 15.67%
3 Industrials 5.36%
4 Technology 4.42%
5 Real Estate 3.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
REXR icon
26
Rexford Industrial Realty
REXR
$8.19B
$3.97M 0.73%
+70,000
New +$4.22M
DALS
27
DELISTED
DA32 Life Science Tech Acquisition Corp. Class A Common Stock
DALS
$3.93M 0.73%
+400,000
New +$3.95M
NTRA icon
28
Natera
NTRA
$46.4B
$3.9M 0.72%
+35,000
New +$4.01M
MCB icon
29
Metropolitan Bank Holding Corp
MCB
$1.15B
$3.79M 0.7%
+45,000
New +$3.28M
SWTX
30
DELISTED
SpringWorks Therapeutics
SWTX
$3.6M 0.67%
56,766
+11,766
+26% +$907K
PCPC
31
DELISTED
Periphas Capital Partnering Corporation
PCPC
$3.56M 0.66%
146,222
– –
SRZN icon
32
Surrozen
SRZN
$301M
$3.54M 0.65%
+33,333
New +$4.69M
AVIR icon
33
Atea Pharmaceuticals
AVIR
$420M
$3.51M 0.65%
100,000
-65,000
-39% -$1.8M
OCDX
34
DELISTED
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
$3.33M 0.61%
+180,000
New +$3.62M
CERT icon
35
Certara
CERT
$1.25B
$3.31M 0.61%
+100,000
New +$3.02M
VINC
36
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$3.23M 0.6%
10,000
+7,547
+308% +$2.2M
PMGM
37
DELISTED
Priveterra Acquisition Corp. II Class A Common Stock
PMGM
$3.2M 0.59%
324,996
– –
THRN
38
DELISTED
Thorne Healthtech, Inc. Common Stock
THRN
$3.08M 0.57%
+356,250
New +$2.91M
ENPC
39
DELISTED
Executive Network Partnering Corporation
ENPC
$3.07M 0.57%
312,490
– –
APG icon
40
APi Group
APG
$18B
$3.05M 0.56%
+225,000
New +$3.26M
XFOR icon
41
X4 Pharmaceuticals
XFOR
$460M
$2.97M 0.55%
18,714
-443
-2% -$72.9K
STT icon
42
State Street
STT
$50.7B
$2.96M 0.55%
+35,000
New +$3.04M
CWAN
43
DELISTED
Clearwater Analytics
CWAN
$2.94M 0.54%
+115,000
New +$2.95M
SNCE
44
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
$2.94M 0.54%
15,000
– –
XENE icon
45
Xenon Pharmaceuticals
XENE
$6.12B
$2.75M 0.51%
+180,000
New +$3.13M
RNAM
46
DELISTED
Avidity Biosciences
RNAM
$2.71M 0.5%
+110,000
New +$2.39M
GMBT
47
DELISTED
Pivotal Holdings Corp Class A Ordinary Share
GMBT
$2.52M 0.47%
250,000
– –
FLACW
48
DELISTED
Frazier Lifesciences Acquisition Corporation Warrant
FLACW
$2.51M 0.46%
299,999
+250,000
+500% +$224K
STER
49
DELISTED
Sterling Check Corp. Common Stock
STER
$2.5M 0.46%
+96,500
New +$2.53M
AGL icon
50
Agilon Health
AGL
$1.6B
$2.49M 0.46%
+3,800
New +$3.25M
1
2
3 4 5

Similar funds

SWMG
Sard Wealth Management Group Atlanta, Georgia $184M AUM 11.26% 1-Year Est. Return
IFPL
Investments & Financial Planning LLC Lexington, Kentucky $184M AUM 17.7% 1-Year Est. Return
RFG
RFP Financial Group Atlanta, Georgia $184M AUM 16.06% 1-Year Est. Return
NAM
Nutshell Asset Management Sevenoaks, United Kingdom $184M AUM 2.02% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return
PSAMP
P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return
GCA
GSI Capital Advisors Newport Beach, California $184M AUM 5.17% 1-Year Est. Return
IVGAV
Index Venture Growth Associates V St. Helier, Jersey $184M AUM

Monashee Investment Management's Q3 2021 Portfolio in Review

As of Q3 2021, Monashee Investment Management held 524 positions worth $542M, down 35% from $836M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Monashee Investment Management withdrew a net $267M in Q3 2021, closing 262 positions and reducing 21 holdings. Its most notable exit was Aveanna Healthcare, an estimated $21.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 33% a quarter earlier, followed by Financials and Industrials.

Against the trend, Monashee Investment Management opened a new position in SomaLogic, Inc. Class A Common Stock worth $18.4M.

  • Monashee Investment Management's largest Q3 2021 buy was SomaLogic, Inc. Class A Common Stock: 1,486,135 shares worth $18.4M.
  • Monashee Investment Management added most to Vanguard Morningstar Total Stock Market ETF in Q3 2021, an estimated $67.8M increase.
  • Monashee Investment Management's biggest Q3 2021 reduction was Cano Health, Inc., cutting an estimated $5.09M.
  • Monashee Investment Management fully exited Aveanna Healthcare in Q3 2021, selling an estimated $21.7M.
  • Monashee Investment Management's ten largest holdings make up 48% of its $542M portfolio in Q3 2021.
  • Monashee Investment Management opened 97 new positions and closed 262 in Q3 2021.
  • Monashee Investment Management's portfolio value fell 35% quarter-over-quarter to $542M.

Based on Monashee Investment Management's 13F filing for Q3 2021, filed 9 Nov 2021.